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Abstract 
Egg specific IgE levels are frequently used in combination with skin‑prick tests to guide clinical decisions and to moni‑
tor egg allergy evolution in children. We compared both Immulite and ImmunoCAP egg specific IgE assays in egg 
allergic children, and found a linear correlation between both assays with a mean Immulite:ImmunoCAP ratio of 3. 
This is relevant information for clinicans wishing to estimate values from one assay to the other, as most literature has 
been published using the ImmunoCAP system.
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Findings
Egg allergy represents one of the most common food 
allergies encountered in pediatric practice, with an esti-
mated prevalence of 0.5–2  % in infants and young chil-
dren [1]. Many egg allergic children are able to tolerate 
baked eggs [2], which can greatly improve quality of life. 
Egg specific IgE levels are frequently used in combina-
tion with skin-prick tests (SPT) to guide clinical deci-
sions and to monitor egg allergy evolution in children. 
Most reports on egg allergy have been using the Immu-
noCAP (Phadia AB, Uppsala, Sweden) assay [3–5], which 
is a problem for the fraction of clinicians who do not 
have access to it, as their lab works with Immulite (Sie-
mens Healthcare Diagnostics, Tarrytown, New York) 
for technical or administrative reasons. In this context, 
clinical literature is challenging to interpret and imple-
ment in practice. Some would recommend simply not 
using this ImmunoCAP literature, but this would mean 
depriving patients from useful information to guide man-
agement and therapy. Interestingly, it has been suggested 
that although egg-specific IgE results from either assays 
cannot be substituted [6], they may be adapted so that 
the results may still be used to guide management [7, 8].
The objective of this study was to directly compare 
Immulite and ImmunoCAP egg white-specific IgE assays 
and to determine whether their measurements can be 
applied equivalently and/or adapted to guide clinical 
management of egg allergic children.
Briefly, 37 egg allergic patients between 2 and 13 years 
of age were enrolled at Sainte-Justine University Hospi-
tal Center (Montreal, Canada) from July 2013 to January 
2014. Patients with egg allergy had either a positive OFC 
or a history of at least one sign or symptom of allergy 
(ocular, respiratory, gastrointestinal, or cardiovascular) 
occurring within 1 h of egg ingestion and persistent sen-
sitization at time of evaluation confirmed by a positive 
egg white skin prick test (3  mm greater than control), 
and either ImmunoCAP specific IgE levels ≥0.35 kU/L or 
Immulite specific IgE levels ≥0.1 kU/L. The project was 
approved by the ethics committee of Sainte-Justine Uni-
versity Hospital Center.
Patients’ serum was aliquoted into two separate 
samples and sent on dry ice for analysis at the labo-
ratories of the University of Montreal Hospital Center 
(CHUM) and Sainte-Justine University Hospital 
Center, each using a different specific IgE assay system: 
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ImmunoCAP Phadia 250 and Siemens DPC Immulite 
2000.
Descriptive analysis consisted of medians and range. 
Immulite and ImmunoCAP values were compared using 
Pearson’s correlation (GraphPad Prism 6, San Diego, CA).
The median age of patients was 6.5  years (range, 
2–13) and the median age at first reaction to eggs was 
12 months (range, 4–96). The age of worst reaction was 
a median of 5.5  years before testing. Eighteen patients 
(49  %) had a history of anaphylactic reactions to eggs 
and 10 (27  %) tolerated baked eggs, while most of the 
remainder had never ingested baked egg before. Median 
egg white skin prick test diameter at time of specific IgE 
measurement was 10 mm (range, 3–25 mm).
In the whole cohort, Immulite median egg white-spe-
cific IgE levels was 24.80 [range, 0.72–100]  kU/L com-
pared to 6.45 [range, 0.33–100] kU/L for ImmunoCAP. In 
the subgroup tolerating baked eggs (n = 10), median egg 
white-specific IgE levels was 5.2 [range, 1.13–28.1] kU/L 
using Immulite and 3.17 [range, 0.38–8.93]  kU/L using 
ImmunoCAP. When examining the subgroup of patients 
with anaphylactic reactions to eggs (n = 18), the median 
egg white-specific IgE levels using Immulite was 17.4 
[range, 0.715–100] kU/L compared to 5.90 [range, 0.33–
100] kU/L for ImmunoCAP.
Thus, as previously suggested, Immulite and Immuno-
CAP egg-specific IgE values could not be substituted [6]. 
However, values were highly correlated (Pearson correla-
tion factor of 0.864; Fig. 1) with egg white-specific IgE lev-
els measured by Immulite a mean of 3.02 (± 0.44) times 
higher than when measured by ImmunoCAP(n  =  29, 
ImmunoCAP values  ≤30  kU/L). This correlation ratio 
was lost with ImmunoCAP values higher than 30 kU/L, 
which likely reflects the fact that values higher than 
100  kU/L for Immulite exceeded the top point of the 
calibration curve. One can expect that diluting the sam-
ples with an appropriate serum diluent and reanalyzing 
the samples would have preserved this linear correlation 
[8]. Interestingly, the ImmunoCAP:Immulite ratio was 
of 1.64 in the subgroup tolerating baked eggs (n =  10). 
The significance of this lower ratio is difficult to interpret 
due to the small n in this sub-group. A possibility is that 
individual allergen components (i.e., ovomucoid vs oval-
bumin) may be measured differently in each assay, which 
would become apparent when comparing subgroups 
with different sensitivity profiles (baked good tolerant vs 
allergic).
These observations are in line with previous studies. 
Wang et  al. found an Immulite:ImmunoCAP ratio of 
3.7 for egg-white specific IgE in 50 atopic patients [6]. 
Although the correlation coefficient was not included, 
qualitatively it appeared to be very high. Another study 
from South Korea evaluated atopic patients 1–75 years of 
age and found a very similar Pearson’s correlation coef-
ficient of 0.845 for egg white-specific IgE when compar-
ing both assays [7]. Hamilton et al. [8] also found a mean 
Immulite:ImmunoCAP ratio of 4.85 and a high coeffi-
cient of determination of 0.95 in children aged 1–16 with 
a history of egg allergy (no skin prick tests or challenge), 
which is comparable to our results.
In conclusion, because of variability between Immulite 
and ImmunoCAP specific IgE assays, it is preferable to 
use a single assay to monitor the evolution of egg allergy 
and to assess the development of tolerance. This said, a 
linear correlation does exist between both assays, as has 
been observed in four independent cohorts including 
ours. Therefore in the absence of access to ImmunoCAP, 
a factor of 3–5 could be applied to egg-specific IgE pub-
lished thresholds to guide clinical decisions. Although 
imperfect, this approach remains in our opinion pref-
erable to withholding useful clinical information from 
patients and clinicians.
Abbreviations
SPT: skin‑prick test; OFC: oral food challenge.
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Fig. 1 Correlation plot of egg white specific IgE levels as measured 
with ImmunoCAP® and Immulite®
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